Pre-filled syringe

DEVICE3 trials

Sponsors

Medical University of Vienna, Diakonhjemmet Sykehus AS, Academisch Ziekenhuis Leiden, Karolinska University Hospital, Hoffmann-La Roche, iOMEDICO AG

Conditions

Breast CancerHepatitis C, ChronicNon Hodgkin LymphomaRheumatoid Arthritis

Phase 1

A Study of Administration of Peginterferon Alfa-2a [Pegasys] by Autoinjector Versus Pre-filled Syringe in Patients With Chronic Hepatitis C

CompletedNCT01087944

Hoffmann-La RocheHepatitis C, Chronic

Start: 2010-03-31End: 2010-06-30Updated: 2016-02-09

Phase 4

An international, multicentre, interventional, randomised assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial)

RecruitingCTIS2023-507714-27-00

Medical University of Vienna, Diakonhjemmet Sykehus AS, Academisch Ziekenhuis Leiden, Karolinska University HospitalRheumatoid Arthritis

Start: 2024-06-20Target: 212Updated: 2026-01-27

Unknown Phase

Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

CompletedNCT03619993

iOMEDICO AGBreast Cancer, Non Hodgkin Lymphoma

Start: 2018-06-25End: 2019-09-10Updated: 2019-12-17

Related Papers

Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients.

2021-05-0610 citations